Australia markets closed

bluebird bio, Inc. (BLE.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
15.900.00 (0.00%)
As of 05:13PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
21,726
3,597
3,662
0
Cost of revenue
23,916
10,077
38,857
0
Gross profit
-2,190
-6,480
-35,195
0
Operating expenses
Research development
179,781
240,764
319,946
319,309
Selling general and administrative
149,113
136,908
209,969
239,950
Total operating expenses
133,964
275,672
529,915
559,259
Operating income or loss
-136,154
-282,152
-565,110
-559,259
Total other income/expenses net
36,690
14,659
1,851
-6,881
Income before tax
-91,137
-266,461
-562,380
-560,370
Income tax expense
30
117
258
686
Income from continuing operations
-91,167
-266,578
-562,638
-561,056
Net income
-91,167
-266,578
-819,378
-618,695
Net income available to common shareholders
-91,167
-266,578
-819,378
-618,695
Basic EPS
-
-
-
-9.95
Diluted EPS
-
-
-
-9.95
Basic average shares
-
-
-
62,178
Diluted average shares
-
-
-
62,178